首页> 外文期刊>Bone marrow transplantation >Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation.
【24h】

Detection of EBV DNA in the cord blood donor for a patient developing Epstein-Barr virus-associated lymphoproliferative disorder following mismatched unrelated umbilical cord blood transplantation.

机译:在不相关的无关脐带血移植后,发展为爱泼斯坦-巴尔病毒相关的淋巴增生性疾病的患者,在脐带血供体中检测EBV DNA。

获取原文
获取原文并翻译 | 示例
       

摘要

Epstein-Barr virus-associated post-transplant lymphoproliferative disorder (PTLD) has been well described as a complication following allogeneic stem cell transplantation but has only recently been reported following umbilical cord blood (UCB) transplant. We report the case of a child transplanted with unrelated mismatched UCB for juvenile chronic myelogenous leukemia (JCML) who developed EBV-associated PTLD, which was confirmed pathologically, 139 days following stem cell infusion. There was no clinical response to reduction of immune suppression, high-dose acyclovir, or alpha interferon. The patient died 160 days after transplantation. EBV was detected by polymerase chain reaction in the cord blood unit used for transplantation. This case demonstrates that EBV-associated PTLD can occur following mismatched unrelated UCB transplant and may be related to transmission of EBV infection by donor lymphocytes.
机译:与爱泼斯坦-巴尔病毒相关的移植后淋巴组织增生性疾病(PTLD)已被描述为同种异体干细胞移植后的并发症,但直到最近才报道了脐带血(UCB)移植后的并发症。我们报告了一名儿童,该儿童移植了不相关的错配的UCB治疗的青少年慢性粒细胞性白血病(JCML),该患者发展出与EBV相关的PTLD,经干细胞输注139天经病理证实。没有对减少免疫抑制,大剂量无环鸟苷或α-干扰素的临床反应。该患者在移植后160天死亡。通过用于移植的脐带血单元中的聚合酶链反应检测到EBV。该病例表明与EBV相关的PTLD可能在不匹配的无关UCB移植后发生,并且可能与供体淋巴细胞对EBV感染的传播有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号